Delta Asset Management’s Takeda Pharmaceutical TAK Stock Holding History

Delta Asset Management’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-201	Closed	-$3.11K	–	702
2023 Q3	$3.11K	Hold	201	–	–	﹤0.01%	556
2023 Q2	$3.16K	Hold	201	–	–	﹤0.01%	560
2023 Q1	$3.31K	Hold	201	–	–	﹤0.01%	532
2022 Q4	$3.14K	Buy	+201	New	+$2.81K	﹤0.01%	561
2022 Q1	–	Sell	-201	Closed	-$3K	–	529
2021 Q4	$3K	Hold	201	–	–	﹤0.01%	579
2021 Q3	$3K	Hold	201	–	–	﹤0.01%	577
2021 Q2	$3K	Hold	201	–	–	﹤0.01%	574
2021 Q1	$4K	Hold	201	–	–	﹤0.01%	537
2020 Q4	$4K	Hold	201	–	–	﹤0.01%	534
2020 Q3	$4K	Hold	201	–	–	﹤0.01%	506
2020 Q2	$4K	Hold	201	–	–	﹤0.01%	518
2020 Q1	$3K	Hold	201	–	–	﹤0.01%	551
2019 Q4	$4K	Hold	201	–	–	﹤0.01%	544
2019 Q3	$3K	Hold	201	–	–	﹤0.01%	557
2019 Q2	$4K	Buy	+201	New	+$3.66K	﹤0.01%	475

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Delta Asset Management's TAK Position: Q4 2023 in Review

Delta Asset Management sold out of Takeda Pharmaceutical (TAK) in Q4 2023, closing a stake of 201 shares — an estimated $3.11K sold.

Delta Asset Management first reported a position in TAK in Q2 2019 and held it in 15 quarters. The position peaked at $4K in Q1 2021. 307 funds tracked by Wall St. Rank hold TAK as of Q4 2023.

Delta Asset Management reported no remaining Takeda Pharmaceutical position as of Q4 2023 after selling out during the quarter.
Delta Asset Management sold 201 Takeda Pharmaceutical shares in Q4 2023, an estimated $3.11K.
Delta Asset Management first reported a position in Takeda Pharmaceutical in Q2 2019 and held it in 15 quarters.
Delta Asset Management's Takeda Pharmaceutical position peaked at $4K in Q1 2021.
307 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2023.

Based on Delta Asset Management's 13F filing for Q4 2023, filed 9 Feb 2024.